|Bid||107.98 x 900|
|Ask||108.01 x 800|
|Day's Range||107.42 - 108.15|
|52 Week Range||83.81 - 108.15|
|PE Ratio (TTM)||28.57|
|Earnings Date||Oct 17, 2018 - Oct 22, 2018|
|Forward Dividend & Yield||0.64 (0.60%)|
|1y Target Est||114.07|
Danaher (DHR) is poised to grow on the back of effective implementation of the Danaher Business System and strategic inorganic moves.
The Zacks Analyst Blog Highlights: Microsoft, Union Pacific, Danaher, Travelers and Northern Trust
Honeywell's (HON) diversified business portfolio enables it to earn consistent above-average returns and mitigate operating risks.
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
WASHINGTON, Sept. 17, 2018 /PRNewswire/ -- Danaher Corporation (DHR) will host a live video webcast of its Mid-Year Investor and Analyst Meeting at Pall on September 18, 2018 beginning at 12:00 p.m. ET. The event will be held at Danaher's Pall facility in Westborough, Massachusetts and hosted by Rainer Blair, Executive Vice President of the Life Sciences platform, and Daniel L. Comas, Executive Vice President and Chief Financial Officer.
When Danaher Corporation (NYSE:DHR) announced its most recent earnings (29 June 2018), I compared it against two factor: its historical earnings track record, and the performance of its industry peersRead More...
WASHINGTON , Sept. 11, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on October 26, ...
WASHINGTON , Sept. 10, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. , will be presenting at the Morgan Stanley Global ...
Today, Align Technology (ALGN) reported a 52-week high of $392.69 per share. The stock momentum has seen strong growth momentum this year on strong quarterly performances and fundamentals. Align is currently trading higher than its 50-day moving average of $366.00 and its 200-day moving average of $308.74. The stock was trading at a 52-week low of $173.88 per share on September 1, 2017.
Tracy Burzycki previously held various senior commercial leadership roles at life-sciences and technology company, Danaher Corp.
Roche’s Diagnostics division consists of Centralized and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. Roche’s Diagnostics division reported revenues of 6.3 billion Swiss francs in the first half, which reflected ~6.0% YoY growth at CER (constant exchange rates).
If you are currently a shareholder in Danaher Corporation (NYSE:DHR), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested.Read More...
NEW YORK, Aug. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of New ...
The Trump administration's trade decisions seem to be the theme of the quarter. While Nucor Corporation (NYSE: NUE) and CSX Corporation (NASDAQ: CSX) celebrated the positive impact of trade policy on finished steel and ore, most corporations lamented the tariffs. Hasbro, Inc. (NASDAQ: HAS), for example, warned of “just how terrible” a tariff or trade war would be.